Deficiency of autotaxin/lysophospholipase D results in head cavity formation in mouse embryos through the LPA receptor-Rho-ROCK pathway

Biochemical and Biophysical Research Communications

Volumn 400, Issue 1, 2010, Pages 66-71

  Koike, Seiichi ^a   Keino Masu, Kazuko ^a   Masu, Masayuki ^a  

^a UNIVERSITY OF TSUKUBA   (Japan)

Author keywords

Autotaxin; Enpp2; Knockout mouse; LPA; Rho; ROCK

Indexed keywords

AUTOTAXIN; LIM KINASE; LYSOPHOSPHATIDIC ACID RECEPTOR; LYSOPHOSPHOLIPASE; LYSOPHOSPHOLIPASE D; PROTEIN KINASE; PROTEIN ROCK; RHO FACTOR; UNCLASSIFIED DRUG; ACTIN; ALKYLGLYCEROPHOSPHOETHANOLAMINE PHOSPHODIESTERASE; INORGANIC PYROPHOSPHATASE; MULTIENZYME COMPLEX; PHOSPHODIESTERASE; PHOSPHODIESTERASE I; RHO KINASE;

ANGIOGENESIS; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; EMBRYO; EMBRYO CULTURE; EMBRYO DEVELOPMENT; ENZYME INHIBITION; HETEROZYGOSITY; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; YOLK SAC; ANIMAL; ANIMAL EMBRYO; ANTAGONISTS AND INHIBITORS; BLOOD VESSEL; GENETICS; HEAD; METABOLISM; MOUSE; MUTANT MOUSE STRAIN;

ACTINS; ANIMALS; BLOOD VESSELS; EMBRYO, MAMMALIAN; HEAD; MICE; MICE, MUTANT STRAINS; MULTIENZYME COMPLEXES; NEOVASCULARIZATION, PHYSIOLOGIC; PHOSPHODIESTERASE I; PHOSPHORIC DIESTER HYDROLASES; PYROPHOSPHATASES; RECEPTORS, LYSOPHOSPHATIDIC ACID; RHO FACTOR; RHO-ASSOCIATED KINASES; SIGNAL TRANSDUCTION; YOLK SAC;

MUS;

EID: 78649237687     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2010.08.008     Document Type: Article

References (32)

1. Tokumura A., Majima E., Kariya Y., Tominaga K., Kogure K., Yasuda K., Fukuzawa K. Identification of human plasma lysophospholipase D, a lysophosphatidic acid-producing enzyme, as autotaxin, a multifunctional phosphodiesterase. J. Biol. Chem. 2002, 277:39436-39442.
2. Umezu-Goto M., Kishi Y., Taira A., et al. Autotaxin has lysophospholipase D activity leading to tumor cell growth and motility by lysophosphatidic acid production. J. Cell Biol. 2002, 158:227-233.
3. Anliker B., Chun J. Cell surface receptors in lysophospholipid signaling. Semin. Cell Dev. Biol. 2004, 15:457-465.
4. Stefan C., Jansen S., Bollen M. NPP-type ectophosphodiesterases: unity in diversity. Trends Biochem. Sci. 2005, 30:542-550.
5. Meyer zu Heringdorf D., Jakobs K.H. Lysophospholipid receptors: signalling, pharmacology and regulation by lysophospholipid metabolism. Biochim. Biophys. Acta 2007, 1768:923-940.
6. van Meeteren L.A., Moolenaar W.H. Regulation and biological activities of the autotaxin-LPA axis. Prog. Lipid Res. 2007, 46:145-160.
7. Noguchi K., Herr D., Mutoh T., Chun J. Lysophosphatidic acid (LPA) and its receptors. Curr. Opin. Pharmacol. 2009, 9:15-23.
8. Clair T., Aoki J., Koh E., et al. Autotaxin hydrolyzes sphingosylphosphorylcholine to produce the regulator of migration, sphingosine-1-phosphate. Cancer Res. 2003, 63:5446-5453.
9. Tanaka M., Okudaira S., Kishi Y., et al. Autotaxin stabilizes blood vessels and is required for embryonic vasculature by producing lysophosphatidic acid. J. Biol. Chem. 2006, 281:25822-25830.
10. van Meeteren L.A., Ruurs P., Stortelers C., et al. Autotaxin, a secreted lysophospholipase D, is essential for blood vessel formation during development. Mol. Cell. Biol. 2006, 26:5015-5022.
11. Ferry G., Giganti A., Coge F., Bertaux F., Thiam K., Boutin J.A. Functional invalidation of the autotaxin gene by a single amino acid mutation in mouse is lethal. FEBS Lett. 2007, 581:3572-3578.
12. Koike S., Keino-Masu K., Ohto T., Sugiyama F., Takahashi S., Masu M. Autotaxin/lysophospholipase D-mediated lysophosphatidic acid signaling is required to form distinctive large lysosomes in the visceral endoderm cells of the mouse yolk sac. J. Biol. Chem. 2009, 284:33561-33570.
13. Fotopoulou S., Oikonomou N., Grigorieva E., et al. ATX expression and LPA signalling are vital for the development of the nervous system. Dev. Biol. 2010, 339:451-464.
14. Osumi-Yamashita N., Ninomiya Y., Eto K. Mammalian craniofacial embryology in vitro. Int. J. Dev. Biol. 1997, 41:187-194.
15. Risau W. Mechanisms of angiogenesis. Nature 1997, 386:671-674.
16. Tam P.P. Postimplantation mouse development: whole embryo culture and micro-manipulation. Int. J. Dev. Biol. 1998, 42:895-902.
17. Coultas L., Chawengsaksophak K., Rossant J. Endothelial cells and VEGF in vascular development. Nature 2005, 438:937-945.
18. Ohta H., Sato K., Murata N., et al. Ki16425, a subtype-selective antagonist for EDG-family lysophosphatidic acid receptors. Mol. Pharmacol. 2003, 64:994-1005.
19. Davis M.D., Clemens J.J., Macdonald T.L., Lynch K.R. Sphingosine 1-phosphate analogs as receptor antagonists. J. Biol. Chem. 2005, 280:9833-9841.
20. Nam S.W., Clair T., Kim Y.S., McMarlin A., Schiffmann E., Liotta L.A., Stracke M.L. Autotaxin (NPP-2), a metastasis-enhancing motogen, is an angiogenic factor. Cancer Res. 2001, 61:6938-6944.
21. Karliner J.S. Lysophospholipids and the cardiovascular system. Biochim. Biophys. Acta 2002, 1582:216-221.
22. Rivera-Lopez C.M., Tucker A.L., Lynch K.R. Lysophosphatidic acid (LPA) and angiogenesis. Angiogenesis 2008, 11:301-310.
23. Teo S.T., Yung Y.C., Herr D.R., Chun J. Lysophosphatidic acid in vascular development and disease. IUBMB Life 2009, 61:791-799.
24. Offermanns S., Mancino V., Revel J.P., Simon M.I. Vascular system defects and impaired cell chemokinesis as a result of Galpha13 deficiency. Science 1997, 275:533-536.
25. Gu J.L., Muller S., Mancino V., Offermanns S., Simon M.I. Interaction of G alpha(12) with G alpha(13) and G alpha(q) signaling pathways. Proc. Natl. Acad. Sci. USA 2002, 99:9352-9357.
26. Yang J., Boerm M., McCarty M., Bucana C., Fidler I.J., Zhuang Y., Su B. Mekk3 is essential for early embryonic cardiovascular development. Nat. Genet. 2000, 24:309-313.
27. Liao H.J., Kume T., McKay C., Xu M.J., Ihle J.N., Carpenter G. Absence of erythrogenesis and vasculogenesis in Plcg1-deficient mice. J. Biol. Chem. 2002, 277:9335-9341.
28. Lelievre E., Bourbon P.M., Duan L.J., Nussbaum R.L., Fong G.H. Deficiency in the p110alpha subunit of PI3K results in diminished Tie2 expression and Tie2(-/-)-like vascular defects in mice. Blood 2005, 105:3935-3938.
29. Rogers J.M., Daston G.P., Ebron M.T., Carver B., Stefanadis J.G., Grabowski C.T. Studies on the mechanism of trypan blue teratogenicity in the rat developing in vivo and in vitro. Teratology 1985, 31:389-399.
30. Lloyd J.B. Cell physiology of the rat visceral yolk sac: a study of pinocytosis and lysosome function. Teratology 1990, 41:383-393.
31. Jollie W.P. Development, morphology, and function of the yolk-sac placenta of laboratory rodents. Teratology 1990, 41:361-381.
32. Bielinska M., Narita N., Wilson D.B. Distinct roles for visceral endoderm during embryonic mouse development. Int. J. Dev. Biol. 1999, 43:183-205.